Project Grant F31DA060687

Award Date 9/13/24
Completion Date 3/31/27
Dollars Obligated $242K
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Milwaukee, WI 53226, USA
Similar Awards
This federal Project Grant award, awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $107,948.00 to The Medical College of Wisconsin, Inc. to conduct research on the effects of concurrent chronic stress and cocaine self-administration on the medial prefrontal cortex (mPFC) microglia and drug choice behavior. The research project, titled "Concurrent Chronic Stress and Cocaine Self-Administration: Understanding...
This $1,790,186 Project Grant awarded by the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to investigate the mechanisms governing stress-immune interactions in people living with HIV (PLWH) and their associated distress and cannabis use disorder (CUD). The research project will use a cross-diagnostic approach to: Determine the hypothalamic-pituitary-adrenal (HPA) and immune response to acute stress among healthy controls, PLWH,...
This federal Project Grant award, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), will support an experimental evaluation of the mechanisms through which acute stress increases motivation to use cannabis in individuals with cannabis use disorder (CUD). The primary aim is to test the causal effect of glucocorticoids on neural reactivity to cannabis cues, and whether this effect depends on co-occurring noradrenergic...
This $376,078 federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports research on the relationship between cannabis use for coping purposes and cannabis use quantity and frequency. The key objectives are to: 1) Experimentally test if cannabis use increases after stress induction among individuals who use cannabis for coping, 2) Examine if social anxiety and inhibitory control moderate the...
The U.S. National Institute on Drug Abuse (NIDA), through the Drug Use and Addiction Research Programs (CFDA 93.279), awarded a $163,568 Project Grant to Brown University to conduct a multimodal study on the relationship between cannabis use, trauma, and self-regulatory cognitive processes. The study aims to examine how decision-making processes, such as reward motivation and inhibitory control, relate to cannabis use among young adults following a potentially traumatic event. The project will...
This federal Project Grant award for $254,250.00, awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research to delineate the neurological circuits and cell types involved in mediating contextual memories and behaviors related to cocaine addiction and relapse vulnerability. The key products of this 2-year (Jul 2024 - Jun 2026) exploratory research project will be: Detailed characterization of the intrinsic properties...
This $844,946 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund research to investigate the epigenetic regulation of inflammasome activation and its modulation by cannabinoids during chronic SIV infection and cocaine use. Specifically, the research will: Examine the epigenetic mechanisms underlying cannabinoid-mediated reduction of cocaine-induced inflammasome activation in blood monocytes, brain, and...
This $350,000 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) will fund a study on the developmental effects of environmental enrichment on minor cannabinoid drug reward and cannabinoid receptor levels. The key objectives are to: 1) investigate whether adolescent environmental enrichment can alter sensitivity to cannabis drugs like delta-8-THC and CBD, and 2) determine if enrichment exposure...
This federal Project Grant award of $145,642 was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The funding supports research by Northwestern University to study the recruitment of arrestin proteins by the cannabinoid 2 receptor (CB2R) and their role in signaling, with a focus on understanding how this process can occur independently of G protein-coupled receptor kinases (GRKs). The research aims to simplify the...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), provides $611,407 to the University of California, Los Angeles (UCLA) for a research project investigating the neuronal circuits through which chronic stress promotes habit formation. The overarching goal is to expose how opposing pathways between the amygdala and striatum can mediate the influence of chronic stress on transitioning from...

This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $242,310 to The Medical College of Wisconsin, Inc. to conduct research on the mechanisms by which the stress hormone corticosterone (CORT) regulates the endocannabinoid signaling system in the prefrontal cortex. The goal is to enhance understanding of how CORT-induced mobilization of the endocannabinoid 2-arachidonoylglycerol (2-AG) may contribute to stress-potentiated relapse in substance use disorder. The research will utilize a range of techniques, including ex vivo whole-cell recordings, self-administration/cocaine seeking paradigms, and fiber photometry to directly measure 2-AG release. Successful completion of this 2.5-year project is expected to provide new insights into the mechanisms underlying CORT's regulation of endocannabinoid signaling, potentially informing the development of therapeutic interventions for substance use disorders.

Generated 4/29/25, 3:22 AM